Ryan Bond
Corporate Officer/Principal chez ACLARION, INC.
Fortune : 491 $ au 30/04/2024
Profil
Ryan Bond is currently the Chief Strategy Officer at Aclarion, Inc. He previously worked as the Director-Healthcare Solutions at NuVasive, Inc. from 2014 to 2018.
Mr. Bond completed his undergraduate degree at The Ohio University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACLARION, INC.
0,02% | 30/09/2023 | 1 250 ( 0,02% ) | 491 $ | 30/04/2024 |
Postes actifs de Ryan Bond
| Sociétés | Poste | Début |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15/09/2021 |
Anciens postes connus de Ryan Bond
| Sociétés | Poste | Fin |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01/09/2018 |
Formation de Ryan Bond
| The Ohio University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACLARION, INC. | Technology Services |
| Entreprise privées | 1 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
